In partial fulfillment of the requirements for the Doctor of Philosophy degree in the Graduate School of Biomedical Sciences, Myrna Hurtado will present a seminar entitled “Copper (II) Complex of Tolfenamic Acid as a Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cell Growth via Downregulating Sp1 and Sp3 Transcription Factors” on June 4, 2018, at 9:00 am in LIB-110. The campus community is invited to attend. A private defense with the advisory committee will immediately follow the seminar.
Ms. Hurtado is a PhD candidate in Biochemistry and Cancer Biology under the supervision of Riyaz Basha, Ph.D., Associate Professor.